CSCarolyn Stoll

Carolyn Stoll

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Carolyn Stoll has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Personalizing cancer risk: a systematic review of risk communication strategies

    by Akila Anandarajah, Rachelle Roy, Grace Cross, Carolyn Stoll, Angela Hardi, Shu Jiang, Graham A. Colditz, Ashley J. Housten

    Purpose: Personalized risk communication (PRCom) can help individuals make informed decisions about electing to undergo cancer screening based on their specific risk. In this systematic review, we examined existing risk communication strategies used in the presentation of PRCom and how they may impact screening-related cognitive and behavioral outcomes. Methods: We searched Embase.com, Ovid-Medline All, Scopus, CINAHL Complete, and CENTRAL Trials (via Cochrane Library) for randomized controlled trials addressing interventions with an element of “personalized” cancer risk communication based on the individual’s risk factors. Results: Eighteen unique studies were included. From these 18 studies, we extracted data on PRCom presentation methods and outcome measures such as knowledge and screening completion. Text was used in the majority of PRCom (56%, n = 10), followed by graphs (39%, n = 7), icon arrays (17%, n = 3), charts (17%, n = 3), graphics (17%, n = 3), and video (6%, n = 1). None of these studies included direct format comparisons. We found that knowledge of risk increased in scenarios where PRCom: 1) combined visual (e.g., videos) and text-based communication; and 2) used verbatim (4/5), rather than gist communication (2/7). Screening completion also increased for PRCom with both visual and text-based communication (3/4). However, knowledge of risk and screening completion were minimally impacted if PRCom used only text/verbal communication (1/3 for knowledge of risk, 0/2 for screening completion) or only visual aids (1/3 for knowledge of risk, 2/5 for screening completion). Conclusion: Future research examining the translation of communication strategies to screening-related cognitive and behavioral outcomes is warranted.


  • Open Access

    Repeated measures of mammographic density and texture to evaluate prediction and risk of breast cancer: a systematic review of the methods used in the literature

    by Akila Anandarajah, Yongzhen Chen, Carolyn Stoll, Angela Hardi, Shu Jiang, Graham A. Colditz

    Purpose: It may be important for women to have mammograms at different points in time to track changes in breast density, as fluctuations in breast density can affect breast cancer risk. This systematic review aimed to assess methods used to relate repeated mammographic images to breast cancer risk. Methods: The databases including Medline (Ovid) 1946-, Embase.com 1947-, CINAHL Plus 1937-, Scopus 1823-, Cochrane Library (including CENTRAL), and Clinicaltrials.gov were searched through October 2021. Eligibility criteria included published articles in English describing the relationship of change in mammographic features with risk of breast cancer. Risk of bias was assessed using the Quality in Prognostic Studies tool. Results: Twenty articles were included. The Breast Imaging Reporting and Data System and Cumulus were most commonly used for classifying mammographic density and automated assessment was used on more recent digital mammograms. Time between mammograms varied from 1 year to a median of 4.1, and only nine of the studies used more than two mammograms. Several studies showed that adding change of density or mammographic features improved model performance. Variation in risk of bias of studies was highest in prognostic factor measurement and study confounding. Conclusion: This review provided an updated overview and revealed research gaps in assessment of the use of texture features, risk prediction, and AUC. We provide recommendations for future studies using repeated measure methods for mammogram images to improve risk classification and risk prediction for women to tailor screening and prevention strategies to level of risk.


  • Open Access

    Studies of parenchymal texture added to mammographic breast density and risk of breast cancer: a systematic review of the methods used in the literature

    by Akila Anandarajah, Yongzhen Chen, Graham A. Colditz, Angela Hardi, Carolyn Stoll, Shu Jiang

    This systematic review aimed to assess the methods used to classify mammographic breast parenchymal features in relation to prediction of future breast cancer including the time from mammogram to diagnosis of breast cancer, and methods for the identification of texture features and selection of features for inclusion in analysis. The databases including Medline (Ovid) 1946-, Embase.com 1947-, CINAHL Plus 1937-, Scopus 1823-, Cochrane Library (including CENTRAL), and Clinicaltrials.gov . were searched through October 2021 to extract published articles in English describing the relationship of parenchymal texture features with risk of breast cancer. Twenty-eight articles published since 2016 were included in the final review. Of these, 7 assessed texture features from film mammograms images, 3 did not report details of the image used, and the others used full field mammograms from Hologic, GE and other manufacturers. The identification of parenchymal texture features varied from using a predefined list to machine-driven identification. Reduction in number of features chosen for analysis in relation to cancer incidence then varied across statistical approaches and machine learning methods. The variation in approach and number of features identified for inclusion in analysis precluded generating a quantitative summary or meta-analysis of the value of these to improve predicting risk of future breast cancers. This updated overview of the state of the art revealed research gaps; based on these, we provide recommendations for future studies using parenchymal features for mammogram images to make use of accumulating image data, and external validation of prediction models that extend to 5 and 10 years to guide clinical risk management. By following these recommendations, we expect to improve risk classification and risk prediction for women to tailor screening and prevention strategies to level of risk.


  • Open Access

    Use of repeated mammograms to evaluate risk of breast cancer: a systematic review of methods used in the literature

    by Akila Anandarajah, Yongzhen Chen, Carolyn Stoll, Angela Hardi, Shu Jiang, Graham A. Colditz

    Objective This systematic review aimed to assess methods used to relate repeated mammographic images to breast cancer risk, including the time from mammogram to diagnosis of breast cancer, and methods for analysis of data from either one or both breasts (averaged or assessed individually). Design A systematic review was performed. Setting The databases including in Medline (Ovid) 1946-, Embase.com 1947-, CINAHL Plus 1937-, Scopus 1823-, Cochrane Library (including CENTRAL), and Clinicaltrials.gov. were searched through October 2021, to extract published articles in English, describing relationship of the change in mammographic features with risk of breast cancer. Participants Women with mammogram images. Main outcome measure Breast cancer incidence. Results Twenty articles were included in the final review. We found that BIRADs and Cumulus were most commonly used for classifying mammographic density and automated assessment was used on more recent digital mammograms. Time between mammograms varied from 1 to 4 years, and only 9 of the studies used more than 2 mammograms to quantify features. One study used a prediction horizon of 5 and 10 years, one used 5 years only and another 10 years only, while in the others the prediction horizon was not clearly defined with investigators using the next screening mammogram. Conclusion This review provided an updated overview of the state of the art and revealed research gaps; based on these, we provide recommendations for future studies using repeated measure methods for mammogram images to make the use of accumulating image data. By following these recommendations, we expect to improve risk classification and risk prediction for women to tailor screening and prevention strategies to level of risk. Strengths and limitations of the study To the best of our knowledge, this is the most recent systematic review on the topic of using multiple mammogram images to define risk of breast cancer. This review was performed strictly following systematic review guidelines including a medical librarian with expertise in searching, multiple independent reviewers involved in study selection and data extraction, and reporting following PRISMA 2020 guidelines. Due to heterogeneity of methods for assessment and classification (categorical and continuous) of mammographic features including breast density and time to breast cancer, we did not perform risk of bias or conduct a meta-analysis. Few studies looked at repeated measures of non-density features.


  • Normative noninvasive bladder function measurements in healthy women: A systematic review and meta‐analysis

    by Jean F. Wyman, Jincheng Zhou, D. Yvette LaCoursiere, Alayne D. Markland, Elizabeth R. Mueller, Laura Simon, Ann Stapleton, Carolyn R. T. Stoll, Haitao Chu, Siobhan Sutcliffe

    Aim: To conduct an evidence synthesis of normative reference values for bladder function parameters in women.Methods: We conducted a systematic review and meta‐analysis of studies reporting bladder function parameters obtained from noninvasive tests in healthy women. Seven databases were searched for relevant studies from inception through December 2018, with manual searching of reference lists. We included English language articles that provided quantitative data on urination frequency, voided and postvoid residual volumes, and uroflowmetry results in women without lower urinary tract symptoms. Study selection, data extraction, and quality assessment were undertaken by at least two independent reviewers. Random‐effects meta‐analytic models were used to derive study‐level pooled mean estimates and 95% confidence intervals.Results: A total of 24 studies (N = 3090 women, age range, 18‐91 years) met eligibility criteria. Pooled mean estimates of bladder function parameters were: 6.6 daytime voids (95% confidence interval (95% CI), 6.2, 7.0), 0.4 nighttime voids (95% CI, 0.0, 0.8), 1577 mL for 24‐hour voided volume (95% CI 1428,1725); 12 mL for postvoid residual volume (95% CI, 4, 20); and 28 mL/sec for maximum flow rate (95% CI, 27,30). Between‐study heterogeneity was high for all outcomes (I2 = 61.1‐99.6%), but insufficient data were available to explore reasons for this high heterogeneity (eg, differences by age).Conclusion: Although summary mean estimates of bladder function parameters were calculated, the wide heterogeneity across studies precludes generalization of these estimates to all healthy women. Further research is needed to determine normative reference values within specific groups, such as those defined by age.


  • Multimorbidity in randomized controlled trials of behavioral interventions: A systematic review.

    by Carolyn R. T. Stoll, Sonya Izadi, Susan Fowler, Sydney Philpott-Streiff, Paige Green, Jerry Suls, Anke C. Winter, Graham A. Colditz

    As the population with multiple chronic conditions (MCC) increases, it is essential that randomized controlled trials (RCTs) consider MCC. Behavioral interventions have the potential to positively impact MCC patient outcomes; however, a comprehensive review of consideration of MCC in these trials has not been conducted. The purpose of this systematic review is to determine the frequency with which participants with MCC are represented in behavioral intervention RCTs targeting chronic illness published 2000-2014. MEDLINE and EMBASE were searched from 2000 to 2014 to identify RCTs testing behavioral interventions among adults with chronic illness. A random sampling selection process was performed to identify 600 eligible studies representative of the literature. Two reviewers independently extracted information on consideration of MCC in eligibility criteria and evaluated the reporting and consideration of MCC in trial analyses. Risk of bias was assessed using the Cochrane Collaboration Risk of Bias Tool. In 600 behavioral intervention RCTs, targeting MCC was rare (4.3%). Exclusion of MCC was common (68.3%) and was done through general, specific, or vague exclusion criteria. 218 (36.3%) trials reported presence of MCCs through general or condition-specific measures. Comorbidities were only considered in 4.8% of all trial analyses. In this comprehensive systematic review of 600 studies published from 2000-2014, RCTs testing behavioral interventions rarely consider individuals with MCC, limiting generalizability. Given the public health relevance and limited evidence base, this work highlights the urgent need to improve the consideration of MCC in clinical trial research. (PsycINFO Database Record (c) 2019 APA, all rights reserved).


  • Top Cited Papers

    The value of a second reviewer for study selection in systematic reviews

    by Carolyn R.T. Stoll, Sonya Izadi, Susan Fowler, Paige Green, Jerry Suls, Graham A. Colditz

    Background: Although dual independent review of search results by two reviewers is generally recommended for systematic reviews, there are not consistent recommendations regarding the timing of the use of the second reviewer. This study compared the use of a complete dual review approach, with two reviewers in both the title/abstract screening stage and the full‐text screening stage, as compared with a limited dual review approach, with two reviewers only in the full‐text stage.Methods: This study was performed within the context of a large systematic review. Two reviewers performed a complete dual review of 15 000 search results and a limited dual review of 15 000 search results. The number of relevant studies mistakenly excluded by highly experienced reviewers in the complete dual review was compared with the number mistakenly excluded during the full‐text stage of the limited dual review.Results: In the complete dual review approach, an additional 6.6% to 9.1% of eligible studies were identified during the title/abstract stage by using two reviewers, and an additional 6.6% to 11.9% of eligible studies were identified during the full‐text stage by using two reviewers. In the limited dual review approach, an additional 4.4% to 5.3% of eligible studies were identified with the use of two reviewers.Conclusions: Using a second reviewer throughout the entire study screening process can increase the number of relevant studies identified for use in a systematic review. Systematic review performers should consider using a complete dual review process to ensure all relevant studies are included in their review.